Court Dismisses Juul’s Petition After FDA Rescinds Marketing Denial Order
WASHINGTON, D.C. — The District of Columbia Circuit U.S. Court of Appeals dismissed a petition for review filed by Juul Labs Inc. (JLI) challenging the Food and Drug Administration’s marketing denial...To view the full article, register now.
Already a subscriber? Click here to view full article